(AMPX) Amprius Technologies - Overview
Sector: Industrials | Industry: Electrical Equipment & Parts | Exchange: NYSE (USA) | Market Cap: 2.209m USD | Total Return: 529.1% in 12m
Avg Trading Vol: 154M USD
Peers RS (IBD): 98.5
EPS Trend: 24.1%
Qual. Beats: 3
Rev. Trend: 92.7%
Qual. Beats: 4
Amprium Technologies, Inc. (NYSE: AMPX) designs and manufactures silicon-anode lithium-ion batteries-branded SiCore and SiMaxx-targeted at mobility sectors, most notably unmanned aerial systems (UAS) and high-altitude pseudo-satellites. Founded in 2008 and based in Fremont, California, the firm positions its high-energy-density cells as a weight-saving solution for emerging aviation applications.
Recent financial filings show the company ended Q4 2025 with $42 million in cash and a net loss of $8.3 million, reflecting continued R&D investment that rose to 22 % of revenue-well above the industry average of 12 % for battery innovators. A strategic partnership announced in March 2026 with a major aerospace OEM aims to certify SiCore cells for payload-critical drone platforms, potentially unlocking a market projected to grow at a 14 % CAGR through 2032.
Macro-level drivers include the rapid expansion of the commercial drone market-expected to reach $45 billion by 2028-and tightening emissions regulations that are pushing aerospace manufacturers toward lighter, higher-capacity battery chemistries. Silicon-anode technology is also gaining traction in the broader EV supply chain, where analysts forecast a 9 % annual increase in demand for next-generation cells.
For a deeper dive into AMPX’s valuation metrics and peer comparisons, you might explore ValueRay’s analytical tools.
- Drone market growth boosts battery demand
- Silicon anode technology adoption drives revenue
- Government contracts secure significant orders
- Raw material costs impact battery production
- Aviation safety regulations influence product development
| Net Income: -44.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.23 > 0.02 and ΔFCF/TA 7.53 > 1.0 |
| NWC/Revenue: 148.7% < 20% (prev 213.3%; Δ -64.62% < -1%) |
| CFO/TA -0.20 > 3% & CFO -31.1m > Net Income -44.0m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 7.08 > 1.5 & < 3 |
| Outstanding Shares: last quarter (132.1m) vs 12m ago 12.94% < -2% |
| Gross Margin: 11.32% > 18% (prev -0.76%; Δ 1.21k% > 0.5%) |
| Asset Turnover: 52.52% > 50% (prev 19.95%; Δ 32.57% > 0%) |
| Interest Coverage Ratio: -1.21 > 6 (EBITDA TTM -19.8m / Interest Expense TTM 19.9m) |
| A: 0.69 (Total Current Assets 126.4m - Total Current Liabilities 17.9m) / Total Assets 156.9m |
| B: -1.39 (Retained Earnings -218.4m / Total Assets 156.9m) |
| C: -0.17 (EBIT TTM -24.1m / Avg Total Assets 139.0m) |
| D: -4.11 (Book Value of Equity -218.3m / Total Liabilities 53.1m) |
| Altman-Z'' Score: -5.48 = D |
| DSRI: 1.41 (Receivables 23.7m/5.58m, Revenue 73.0m/24.2m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.71 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 3.02 (Revenue 73.0m / 24.2m) |
| TATA: -0.08 (NI -44.0m - CFO -31.1m) / TA 156.9m) |
| Beneish M-Score: -1.50 (Cap -4..+1) = D |
Over the past week, the price has changed by -5.07%, over one month by +45.47%, over three months by +113.69% and over the past year by +529.10%.
- StrongBuy: 4
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| ISSUER | TARGET | UP/DOWN |
|---|---|---|
| Wallstreet Target Price | 20 | 18.6% |
| Analysts Target Price | 20 | 18.6% |
P/B = 23.0135
Revenue TTM = 73.0m USD
EBIT TTM = -24.1m USD
EBITDA TTM = -19.8m USD
Long Term Debt = 39.9m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 4.67m USD (from shortTermDebt, last quarter)
Debt = 39.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -50.6m USD (from netDebt column, last quarter)
Enterprise Value = 2.16b USD (2.21b + Debt 39.9m - CCE 90.5m)
Interest Coverage Ratio = -1.21 (Ebit TTM -24.1m / Interest Expense TTM 19.9m)
EV/FCF = -60.73x (Enterprise Value 2.16b / FCF TTM -35.5m)
FCF Yield = -1.65% (FCF TTM -35.5m / Enterprise Value 2.16b)
FCF Margin = -48.67% (FCF TTM -35.5m / Revenue TTM 73.0m)
Net Margin = -60.30% (Net Income TTM -44.0m / Revenue TTM 73.0m)
Gross Margin = 11.32% ((Revenue TTM 73.0m - Cost of Revenue TTM 64.7m) / Revenue TTM)
Gross Margin QoQ = 23.65% (prev 15.49%)
Tobins Q-Ratio = 13.76 (Enterprise Value 2.16b / Total Assets 156.9m)
Interest Expense / Debt = 1.63% (Interest Expense 649k / Debt 39.9m)
Taxrate = 21.0% (US default 21%)
NOPAT = -19.1m (EBIT -24.1m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 7.08 (Total Current Assets 126.4m / Total Current Liabilities 17.9m)
Debt / Equity = 0.38 (Debt 39.9m / totalStockholderEquity, last quarter 103.8m)
Debt / EBITDA = 2.56 (negative EBITDA) (Net Debt -50.6m / EBITDA -19.8m)
Debt / FCF = 1.42 (negative FCF - burning cash) (Net Debt -50.6m / FCF TTM -35.5m)
Total Stockholder Equity = 88.5m (last 4 quarters mean from totalStockholderEquity)
RoA = -31.67% (Net Income -44.0m / Total Assets 156.9m)
RoE = -49.74% (Net Income TTM -44.0m / Total Stockholder Equity 88.5m)
RoCE = -18.79% (EBIT -24.1m / Capital Employed (Equity 88.5m + L.T.Debt 39.9m))
RoIC = -21.53% (negative operating profit) (NOPAT -19.1m / Invested Capital 88.5m)
WACC = 11.87% (E(2.21b)/V(2.25b) * Re(12.06%) + D(39.9m)/V(2.25b) * Rd(1.63%) * (1-Tc(0.21)))
Discount Rate = 12.06% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 22.14%
[DCF] Fair Price = unknown (Cash Flow -35.5m)
EPS Correlation: 24.13 | EPS CAGR: 4.89% | SUE: 2.34 | # QB: 3
Revenue Correlation: 92.71 | Revenue CAGR: 93.82% | SUE: 1.49 | # QB: 4
EPS next Quarter (2026-06-30): EPS=-0.01 | Chg7d=+0.023 | Chg30d=+0.027 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=-0.07 | Chg7d=+0.059 | Chg30d=+0.063 | Revisions Net=+1 | Growth EPS=+60.8% | Growth Revenue=+72.7%
EPS next Year (2027-12-31): EPS=0.10 | Chg7d=+0.090 | Chg30d=+0.073 | Revisions Net=+0 | Growth EPS=+255.0% | Growth Revenue=+59.7%
[Analyst] Revisions Ratio: +1.00 (1 Up / 0 Down within 30d for Current Year)